CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,411 | -39.2% | 9,616 | -30.2% | 0.02% | -55.6% |
| Q2 2023 | $185,028 | +17.2% | 13,767 | +44.6% | 0.05% | +5.9% |
| Q1 2023 | $157,808 | -57.4% | 9,518 | -52.2% | 0.05% | -58.5% |
| Q4 2022 | $370,028 | +5.4% | 19,894 | -27.3% | 0.12% | -28.9% |
| Q3 2022 | $351,000 | +112.7% | 27,354 | +15.9% | 0.17% | +69.6% |
| Q2 2022 | $165,000 | -31.0% | 23,595 | -18.2% | 0.10% | -15.0% |
| Q1 2022 | $239,000 | +7.7% | 28,856 | -11.8% | 0.12% | +16.5% |
| Q4 2021 | $222,000 | – | 32,733 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |